Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-17-002820

Options or other derivatives

  • Chief Operating Officer acquired 2,072,976 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
TAYTON-MARTIN HELEN KATRINA Chief Operating Officer 2017-01-13 Grant or award · Option to purchase Ordinary Shares +2,072,976 2,072,976 D
Loading xslF345X03/a4.xml…